Luder CM, Nordmann TM, Ramelyte E, et al. Histiocytosiscutaneous manifestations of hematopoietic neoplasm and
non-neoplastic histiocytic proliferations....
Zwart-Storm EAD, Marion AMWV, Gorter SL, Frank J,
Kelleners-Smeets NWJ. Multicentric reticulohistiocytosis: case
report. Int J Dermatol. 2007;46:39–41.
Kutlubay Z, Bairamov O, Sevim A, Demirkesen C, Mat MC.
Rosai-dorfman disease: a case report with nodal and
cutaneous involvement and review...
Frater JL, Maddox JS, Obadiah JM, Hurley MY. Cutaneous rosaidorfman disease: comprehensive review of cases reported in
the medical literature...
Bolognia JL, Schaffer JV, Cerroni L. Histiocitosis. Dermatología.
4a edición. Barcelona: Elsevier; 2018. p. Cap 91.
Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines
for the diagnosis and clinical management of ErdheimChester disease. Blood. 2014;124:483–492.
Ortiz Salvador JM, Subiabre Ferrer D, Pérez Ferriols A.
Enfermedad xantogranulomatosa orbitaria del adulto. Formas
clínicas, evaluación y...
Gómez LV, Restrepo R, Buchely N. Histiocitosis, una visión
práctica para el dermatólogo. Rev Asoc Colomb Dermatol Cir
Dermatol. 2016;24:186–203.
Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults:
advances in pathophysiology and treatment. Cancer Sci. 2018;
109:3707–3713.
Lindahl LM, Fenger-Grøn M, Iversen L. Topical nitrogen
mustard therapy in patients with langerhans cell
histiocytosis. Br J Dermatol. 2012;166:642–645.
Oneal PA, Kwitkowski V, Luo L, et al. FDA approval summary:
vemurafenib for the treatment of patients with ErdheimChester disease with the...
Aubart FC, Emile J-F, Carrat F, et al. Targeted therapies in 54
patients with Erdheim-Chester disease, including follow-up
after interruption...
Diamond EL, Durham BH, Ulaner GA, et al. Efficacy of MEK
inhibition in patients with histiocytic neoplasms. Nature. 2019;
567:521–524.
Saunders IM, Goodman AM, Kurzrock R. Real-world toxicity
experience with BRAF/MEK inhibitors in patients with
Erdheim-Chester disease. Oncologist....
Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic
xanthogranuloma – a systematic review. J Eur Acad Dermatol
Venereol. 2017;31:221–235.
Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of RosaiDorfman-Destombes disease....